Clinical Research Center for Dementia of South Korea (CREDOS)(or CRCD)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2012 by Samsung Medical Center
Sponsor:
Collaborator:
Ministry of Health & Welfare, Korea
Information provided by (Responsible Party):
Doh Kwan Kim, Samsung Medical Center
ClinicalTrials.gov Identifier:
NCT01198093
First received: September 8, 2010
Last updated: September 26, 2012
Last verified: September 2012

September 8, 2010
September 26, 2012
November 2005
August 2015   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01198093 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Clinical Research Center for Dementia of South Korea (CREDOS)(or CRCD)
Clinical Research Center for Dementia of South Korea (CREDOS)

The objective of this study is to present evidence-based medicine for development of clinical practice guideline through prospective study of Alzheimer's disease(AD) and mild cognitive impairment(MCI) in korea

The specific aims of this study is (1) construction & maintenance of cohort for Alzheimer's disease(AD) and mild cognitive impairment(MCI); (2) study of epidemiology, rate of progression, risk factor, prognostic factor; (3) study of biomarker such as neuropsychological assessment, peripheral & CSF markers, neuroimaging(both structural & functional)

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

Serum, plasma and DNAs were prepared

Non-Probability Sample
  1. Patient populatin who is suffering from memory impairment
  2. Normal subjects matched with age and gender
Alzheimer's Disease
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
800
August 2015
August 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Alzheimer's disease(AD) and mild cognitive impairment(MCI)will be enrolled in the study.

    1. the diagnostic criteria of Alzheimer's disease(AD) according to DSM IV or NINCDS -ADRDA
    2. the diagnostic criteria of mild cognitive impairment(MCI) A. Memory or other cognitive complaint preferably corroborated by an informant B. Objective memory impairment or other cognitive for age and education C. Largely intact general cognitive function D. Essentially preserved ADL E. Not demented

Exclusion Criteria:

  • Exclusion criteria are current neurological or other psychiatric disorders, as well as a history of epileptic seizures, substantial brain damage or neurosurgical operation, according to established safety criteria.
Both
Not Provided
Yes
Contact: Doh K Kim, Ph.D 82-2-3410-3582 dohkwan.kim@samsung.com
Korea, Republic of
 
NCT01198093
2005-02-008
Yes
Doh Kwan Kim, Samsung Medical Center
Samsung Medical Center
Ministry of Health & Welfare, Korea
Principal Investigator: Doh K KIm, Ph.D Ministry of Health and Welfare
Samsung Medical Center
September 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP